Search

everythinglearnresearchcommunity

for

Search:↓

One-third of COVID-19 patients had long-term symptoms like hair loss and fatigue, with women, older individuals, blood group B, smokers, and those with more virus exposure at higher risk.

Different types of persistent hair loss after chemotherapy respond differently to treatments.

Gender differences affect allergy prevalence, severity, and response to environmental toxins, with women often more affected than men.

A patient with PPP had rare skin reactions to adalimumab, which improved after stopping smoking and continuing acitretin.

Sacituzumab govitecan improves quality of life and symptoms in breast cancer patients, except for causing more diarrhea.

Patients with long COVID after Omicron had fewer hospitalizations and milder symptoms but more fatigue, insomnia, and cough compared to those with Delta.

A standardized drug development platform is essential for efficient and effective drug repurposing, especially during pandemics.

The ACE1 gene variant doesn't affect long-COVID symptoms.

Many patients with various medical conditions experience anxiety, which worsens their quality of life and raises healthcare costs.

Higher doses of isotretinoin may lead to more hair loss.

Low-dose oral minoxidil can be effective for hair loss but should be avoided in people with certain heart conditions and severe liver problems.

Managing myasthenia gravis is crucial and does not worsen primary Sjögren's syndrome.

A Doberman Pinscher had a rare form of autoimmune disease causing hair loss and other severe symptoms.

Targeting amphiregulin may improve treatment for fibrosis and cancer.

Interest in long-COVID symptoms in Japan increased with COVID-19 case peaks, especially for hair loss, cough, smell/taste issues, and headache.

HER2-targeted or hormonal therapies improve quality of life for Sudanese breast cancer patients.

Pediatric pemphigus is often diagnosed late, but rituximab helps control it long-term.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.

Targeting amphiregulin may improve treatment for fibrotic diseases and cancer.

Inhaling medicine may reduce side effects and improve treatment for a major lung cancer type.

People with hair loss conditions may also have thyroid disorders, but more research is needed to understand the connection.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

Low-dose chemotherapy is safer, more effective, and cost-effective than surgery for treating bone lesions in children.

Ellagic acid can help treat skin issues, but its effectiveness is limited by poor absorption, so new delivery methods are being explored.

Most COVID-19 survivors developed post-acute symptoms, especially if they had been in the ICU, but the severity of initial infection didn't predict these symptoms.

FMH foods may help manage post-acute COVID-19 symptoms safely and easily.

The donkey had a severe disease affecting multiple organs and was euthanized.

Many people in Thailand have lingering symptoms after recovering from COVID-19.

Raccoon dogs in Schleswig-Holstein, Germany, were found with sarcoptic mange, showing severe skin issues and potential for spreading the disease.

Early detection and personalized treatment are crucial to prevent Barrett's esophagus from becoming cancer.